Squarepoint
AZN icon

Squarepoint’s AstraZeneca AZN Stock Holding History

Squarepoint’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-130,450
Closed -$24M – 4265
2025
Q4 		$24M Buy
130,450
+54,900
+73% +$9.63M 0.03% 661
2025
Q3 		$11.6M Sell
75,550
-30,000
-28% -$4.54M 0.01% 1002
2025
Q2 		$14.8M Buy
105,550
+11,350
+12% +$1.59M 0.02% 903
2025
Q1 		$13.8M Sell
94,200
-107,750
-53% -$15.6M 0.02% 873
2024
Q4 		$26.5M Buy
201,950
+4,750
+2% +$665K 0.03% 629
2024
Q3 		$30.7M Buy
197,200
+108,300
+122% +$17.5M 0.05% 412
2024
Q2 		$13.9M Sell
88,900
-85,850
-49% -$12.9M 0.02% 767
2024
Q1 		$23.7M Buy
174,750
+58,950
+51% +$7.81M 0.04% 537
2023
Q4 		$15.6M Buy
115,800
+30,200
+35% +$3.93M 0.03% 690
2023
Q3 		$11.6M Buy
85,600
+27,900
+48% +$3.81M 0.03% 733
2023
Q2 		$8.26M Sell
57,700
-198,900
-78% -$29.3M 0.03% 776
2023
Q1 		$35.6M Buy
256,600
+92,850
+57% +$12.5M 0.15% 136
2022
Q4 		$22.2M Buy
163,750
+136,400
+499% +$17.1M 0.09% 229
2022
Q3 		$3M Buy
27,350
+19,650
+255% +$2.49M 0.02% 1047
2022
Q2 		$1.02M Buy
+7,700
New +$1.01M 0.01% 1588

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Squarepoint's AZN Position: Q2 2026 in Review

Squarepoint sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 9,582 shares — an estimated $1.89M sold.

Squarepoint first reported a position in AZN in Q4 2016 and held it in 27 quarters. The position peaked at $34.7M in Q4 2023. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Squarepoint reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 9,582 AstraZeneca shares in Q2 2026, an estimated $1.89M.
  • Squarepoint first reported a position in AstraZeneca in Q4 2016 and held it in 27 quarters.
  • Squarepoint's AstraZeneca position peaked at $34.7M in Q4 2023.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.